New: NCI-funded clinical trial search
Mednet Logo

How do you stereotactically treat brain metastases greater than 3 cm +/- additional brain mets?

It is my impression that for brain metastases >3 cm it may be preferable to deliver fractionated SRT versus the RTOG dose of 15 Gy SRS, if WBRT is omitted. If delivering fractionated SRT, is there a current optimal scheme? I am familiar with 5 Gy x 5 to a 1 mm PTV, but am also aware that some are giving 6Gy x 5 (EQD2 >=35 Gy) or 8Gy x 3. Is there a current "right dose" or range of dose fractionation schemes? In a related question, what is the best approach when there is a met >3cm with perhaps 2 or 3 smaller distributed mets <= 2 cm? Hypofractionate all or SRT the larger lesion and SRS the smaller ones?
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · Yale School of Medicine
Answered on

Interestingly, we have had a number of cases where a patient presents with several small (0.5-1 cm mets) and a single dominant lesion (3-5 cm), particuarly in melanoma. Becuase of a presumed radioresistance for melanoma, we have desired to use as much single fraction or hypo-fractionation as possible to acheive high doses in a short period of time with stereotactic set-up. To this end, we have treated several patients with single fraction GKRS (e.g., 22 Gy) to the small lesions and then deliver ...

Join for free or sign in to see the full answer